Abstract
PAEDIATRIC- FRIENDLY MULTI-DRUG POLYMERIC NANOPARTICLES FOR MANAGEMENT OF AIDS AND TUBERCULOSIS

V. Raichur, M. Mathur, A. Khan and V. Kusumdevi*

ABSTRACT

AIDS is one of the most widely prevalent diseases affecting the paediatric population and the treatment becomes difficult due to the age related barriers. Further anti-retroviral therapy has been less effective due to lack of efficacy and other drug related issues. Nanoparticulate approach is preferred for improving the physicochemical attributes of these classes of drugs. Nevirapine, Lamivudine, Stavudine and isoniazid nanoparticles were prepared as a part of the effective ART plan of WHO by nanoprecipitation and double emulsification method respectively. The prepared nanoparticles were optimised by factorial design using design expert with the nanoparticles having particle size <300 nm with a spherical and smooth surface as per SEM analysis. IR analysis proved that the drugs were compatible with the excipients used for the nanoparticulate formulation. The entrapment was found to be >60 % with the nanoparticles showing an ex-vivo permeation of 24 hours across sheep mucosa. Cellular uptake studies showed a greater internalisation of NP's in the Hela cells hence supporting the greater permeation of NP's as compared to pure drugs. This will further help develop a platform technology for incorporation of the NP's into a suitable drug delivery system compatible with pediatric population.

Keywords: Anti-retrovirals, Nanoparticles, Scanning Electron Microscope (SEM), Cellular Uptake, ex-vivo permeation.


[Full Text Article]   [Download Certificate]

Indexing

Best Article Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue :

Dr. Dhrubo Jyoti Sen

Download Article : Click here

News & Updation

  • EJBPS: JULY ISSUE PUBLISHED

    JULY 2026 Issue has been successfully launched on 1 JULY 2026.

  • EJBPS: New Impact Factor 2026

    EJBPS Impact Factor has been Increased from  7.482 to 8.181 for Year 2026.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

Google Scholar Index Copernicus Indian Science Publications Urlich's Periodicals Directory, Proquest, UK (In Process) Research Bible, Fuchu, Tokyo. JAPAN UDLedge Science Citation Index International Society for Research activity (ISRA) Scientific Indexing Services (SIS) InfoBase Index (In Process) SJIF Impact Factor Scholar Article Impact Factor, SAIF Universal Impact Factor CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Global Impact Factor (GIF) (0.377) IP Indexing (IP Value 3.77) Web of Science Group (Under Process) Directory of Research Journals Indexing Scope Database Academia Academia Doi-Digital Online Identifier Doi-Digital Online Identifier ISSN National Centre Zenodo Indexing International CODEN Service, USA

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT